Patrick J. Heron - Jun 9, 2021 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director, 10%+ Owner
Signature
/s/ Keith Klein, as Attorney-in-Fact for Patrick J. Heron
Stock symbol
ARQT
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
4
Date filed
6/11/2021, 04:35 PM
Previous filing
Jun 8, 2021
Next filing
Jul 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARQT Stock Option (Right to Buy) Award $0 +13.4K $0.00 13.4K Jun 9, 2021 Common Stock 13.4K $27.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of (i) the first anniversary of June 9, 2021 or (ii) the next Annual Meeting following June 9, 2021, subject to Reporting Person's continuous service as a director until such vesting date.